Anchor Capital Advisors LLC Amgen Inc Transaction History

Anchor Capital Advisors LLC

$3.51 Billion
Q3 2024

A detailed history of Anchor Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 1,235 shares of AMGN stock, worth $350,258. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,235

Previous 1,235 -0.0%

Holding current value

$350,258

Previous $385,000 3.12%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $40,835 - $45,442	-177 Reduced 12.54%	1,235 $300,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $38,810 - $42,934	177 Added 14.33%	1,412 $341,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $654,024 - $725,592	-2,800 Reduced 69.39%	1,235 $301,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 1.22%	4,035 $1 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 4.67%	4,085 $1.04 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $14,758 - $18,969	-78 Reduced 1.79%	4,285 $1.03 Million
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $83,224 - $99,720	478 Added 12.3%	4,363 $844,000
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 1.27%	3,885 $805,000
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $653,406 - $733,916	3,935 New	3,935 $726,000
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $334,624 - $391,050	-1,975 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $330,397 - $377,225	1,975	1,975 $368,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Capital Advisors LLC with notifications on news.

Account

Anchor Capital Advisors LLC Amgen Inc Transaction History